Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 8/20 | 0.57 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.51 |
| ▸ | CA2 | P00918 | 7/20 | 0.49 |
| ▸ | CA9 | Q16790 | 6/20 | 0.49 |
| ▸ | CA12 | O43570 | 5/20 | 0.49 |
| ▸ | CA1 | P00915 | 5/20 | 0.49 |
| ▸ | CA7 | P43166 | 2/20 | 0.49 |
| ▸ | CA4 | P22748 | 2/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113508 | 0.82 | PTGS2 (0.78) | PTGS2PTGS1CA2CA9CA12 | |
| SCHEMBL9492457 | 0.80 | PTGS2 (0.75) | PTGS2PTGS1CA2CA9CA12 | |
| Hydrochloric Acid SCHEMBL29969073 | 0.80 | PTGS2 (0.75) | PTGS2PTGS1CA2CA9CA12 | |
| SCHEMBL7776206 | 0.80 | PTGS2 (0.75) | PTGS2PTGS1CA2CA9CA12 | |
| Iodide SCHEMBL28542044 | 0.80 | PTGS2 (0.75) | PTGS2PTGS1CA2CA9CA12 | |
| SCHEMBL2933802 | 0.78 | RAB9A (0.47) | CA2CA9CA12CA1CA7 | |
| SCHEMBL16540410 | 0.77 | ALDH1A1 (0.79) | PTGS2PTGS1CA2CA9CA12 | |
| SCHEMBL6849995 | 0.77 | PTGS2 (0.72) | PTGS2PTGS1CA2CA9CA12 | |
| SCHEMBL28388013 | 0.75 | PTGS2 (0.68) | PTGS2PTGS1CA2CA9CA12 | |
| Benzenesulfonamide SCHEMBL8827160 | 0.75 | PTGS2 (0.68) | PTGS2PTGS1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322193-A | EGFR and/or HER2 inhibitors and methods of use | 达纳-法伯癌症研究所股份有限公司 | 2022-11-11 | — | — | CN | disclosed |